Blood inflammation markers and health in dialysis patients
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks at how certain blood test results (related to inflammation) affect people on dialysis. It may help doctors understand more about health risks for dialysis patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have end-stage renal disease (kidney failure requiring dialysis)
- Have been on hemodialysis for at least 3 months
- Do not have an autoimmune disease, liver cirrhosis, a weakened immune system, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether two simple blood tests (D-dimer and CRP) can help predict heart problems in people on dialysis. If you join, they would check these markers in your blood and see if they relate to your heart health.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at whether certain substances in the blood, such as uric acid, homocysteine, and interleukin-17, are higher in people with lupus-related kidney disease compared to healthy individuals. It aims to find new ways to monitor or understand the condition better.
This study looks at two blood tests (albumin/globulin ratio and platelet/albumin ratio) to see if they can help understand lupus nephritis, a serious kidney problem caused by lupus. If you have lupus nephritis, your participation may help improve how doctors monitor and manage this condition.
This study looks at blood markers related to iron and other body processes (like minerals, liver function, and inflammation) in people receiving hemodialysis. The results may help doctors better understand what affects health in dialysis patients.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
Hear when a new Hemodialysis Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.